myelodysplatic syndromes – Patient Worthy

source: pixabay.com

Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation

Post author:James Moore
Post published:August 30, 2019
Post category:Myelodysplastic syndromes Pancreatic Cancer Rare Disease

According to a story from BioSpace, the biopharmaceutical company CrystalGenomics, Inc. recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational drug candidate CG-745 Orphan…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More